N-thiazol-2-ylmalonamic acid | 78096-15-8

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: N-thiazol-2-ylmalonamic acid
• 英文别名: N-Thiazol-2-yl-malonamidsaeure；3-Oxo-3-(thiazol-2-ylamino)propanoic acid；2-[(1,3-Thiazol-2-yl)carbamoyl]acetic acid；3-oxo-3-(1,3-thiazol-2-ylamino)propanoic acid
• CAS: 78096-15-8
• 化学式: C₆H₆N₂O₃S
• 分子量: 186.191
• InChiKey: BCETWEVGXCGUAQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  108
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  N-thiazol-2-ylmalonamic acid 以 N,N-二甲基甲酰胺 为溶剂， 反应 16.0h， 生成 4-methyl-2-oxo-1,2-dihydroquinoline-3-carboxylic thiazol-2-ylamide
  参考文献：
  名称：

  4-hydroxy-2-quinolones. 153*. Synthesis of hetarylamides of 4-methyl-2-oxo-1,2-dihydroquinoline-3-carboxylic acid

  摘要：

  4-Methyl-2-oxo-1,2-dihydroquinoline-3-carboxylic acid hetarylamides can be prepared by two fundamentally different routes with allowance made for the thermal stability of the starting hetarylamines.

  DOI：

  10.1007/s10593-009-0266-y
• 作为产物：
  描述：

  methyl 2-(thiazol-2-ylcarbamoyl)acetate 在 lithium hydroxide 作用下， 以 四氢呋喃 、 甲醇 、 水 为溶剂， 生成 N-thiazol-2-ylmalonamic acid
  参考文献：
  名称：

  Novel malonamide derivatives as potent κ opioid receptor agonists

  摘要：

  A novel series of malonamide derivatives was synthesized. These amides were shown to be potent and selective kappa opioid receptor agonists. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2007.01.053

文献信息

• Inhibitors of VEGF receptor and HGF receptor signaling
  申请人：Saavedra Mario Oscar

  公开号：US20070004675A1

  公开（公告）日：2007-01-04

  The invention relates to the inhibition of VEGF receptor signaling and HGF receptor signaling. The invention provides compounds and methods for inhibiting VEGF receptor signaling and HGF receptor signaling. The invention also provides compositions and methods for treating cell proliferative diseases and conditions

  该发明涉及抑制VEGF受体信号和HGF受体信号。该发明提供了抑制VEGF受体信号和HGF受体信号的化合物和方法。该发明还提供了治疗细胞增殖性疾病和病况的组合物和方法。
• Amide derivatives and methods of their use
  申请人：Dolle E. Roland

  公开号：US20050107355A1

  公开（公告）日：2005-05-19

  Amide derivatives of the general formulae Ia and Ib: are disclosed. Pharmaceutical compositions containing these compounds, and methods for their use, inter alia, for treating and/or preventing gastrointestinal disorders, pain, and pruritus are also disclosed.

  一般式Ia和Ib的酰胺衍生物已被披露。还披露了含有这些化合物的药物组合物，以及用于治疗和/或预防胃肠道疾病、疼痛和瘙痒等的方法。
• Syntheses and antiinflammatory activity of malonamic acid, malonamate and malonamide derivatives of some heterocyclic compounds.
  作者：TOYOSHI KATAGI、MISAKO AOKI、MASAKO KASHIWAGI、KATSUYA OHATA、SHIGEKATSU KOHNO、TAMOTSU MURATA、TAKESHI INOI

  DOI：10.1248/cpb.33.4878

  日期：——

  Malonamate, malonic acid and malonamide derivatives of heterocyclic compounds were synthesized as part of a search for new biologically active compounds, e. g., those having antiinflammatory activity. Malonamates (1-17) were prepared by the reaction of amines containing heterocycles with malonic acid monoethyl ester. Hydrolysis of the malonamates gave the malonamic acids (18-24) in good yields. Malonamides (25-43) were synthesized by condensing amines with N-substituted malonamic acids. The antiinflammatory activity of these compounds was examined against carrageenin-induced rat paw edema. N-[2-(6-Methoxy) benzothiazolyl] malonamic acid (23) and its ethyl ester (7) showed significant activity.

  作为寻找新生物活性化合物（例如具有抗炎活性的化合物）的一部分，合成了异环化合物的丙二酸酯、丙二酸和丙二酰胺衍生物。通过将含异环的胺与丙二酸单乙酯反应制备了丙二酸酯（1-17）。丙二酸酯的水解得到丙二胺酸（18-24），产率良好。通过将胺与N取代的丙二胺酸缩合，合成了丙二胺（25-43）。这些化合物的抗炎活性在卡拉胶诱导的大鼠足部水肿中进行了测试。N-[2-(6-甲氧基)苯并噻唑基]丙二胺酸（23）及其乙基酯（7）显示出显著的活性。
• Fused heterocycles as inhibitors of VEGF receptor and HGF receptor signaling
  申请人：Methylgene Inc.

  公开号：US08093264B2

  公开（公告）日：2012-01-10

  The invention relates to the inhibition of VEGF receptor signaling and HGF receptor signaling. The invention provides compounds of general formula (A) wherein A1 is sulfur, A3 is CH, A2 is CH, D is heterocycle, Z is oxygen, SO0-2 or NR, Ar is phenyl and G is not a ring, and methods for inhibiting VEGF receptor signaling and HGF receptor signaling. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.

  本发明涉及抑制VEGF受体信号和HGF受体信号的方法。本发明提供了通式（A）的化合物，其中A1为硫，A3为CH，A2为CH，D为杂环，Z为氧，SO0-2或NR，Ar为苯基，G不是环，并提供了抑制VEGF受体信号和HGF受体信号的方法。本发明还提供了用于治疗细胞增殖性疾病和病症的组合物和方法。
• INHIBITORS OF VEGF RECEPTOR AND HGF RECEPTOR SIGNALING
  申请人：Saavedra Oscar Mario

  公开号：US20120083482A1

  公开（公告）日：2012-04-05

  The invention relates to the inhibition of VEGF receptor signaling and HGF receptor signaling. The invention provides compounds of general formula (A) wherein A 1 is sulfur, A 3 is CH, A 2 is CH, D is heterocycle, Z is oxygen, SO 0-2 or NR, Ar is phenyl and G is not a ring, and methods for inhibiting VEGF receptor signaling and HGF receptor signaling. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.

  本发明涉及抑制VEGF受体信号和HGF受体信号的技术。本发明提供了通式（A）的化合物，其中A1为硫，A3为CH，A2为CH，D为杂环，Z为氧，SO0-2或NR，Ar为苯基，G不是环，并提供了抑制VEGF受体信号和HGF受体信号的方法。本发明还提供了治疗细胞增殖性疾病和病情的组合物和方法。